Delivery Order SPE2DB22D2009-SPE2DB25FL7RL

Award Date 2/3/25
Potential Completion Date 2/4/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug Mounjaro (tirzepatide) 5 mg/0.5 mL pens. The contract has a ceiling value of $20,165.02 and a period of performance through October 26, 2023. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication Mounjaro (tirzepatide) 7.5 mg/0.5 mL pen. The order has a ceiling value of $5,260 and a period of performance through October 28, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
This is a delivery order for the pharmaceutical product Mounjaro (tirzepatide) 10 mg/0.5 ml pen, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation (Amerisourcebergen), a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract has a ceiling value of $34,821.91 and is a firm fixed-price arrangement. The order was placed under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication Mounjaro (tirzepatide) 7.5 mg/0.5 mL pens. The contract has a ceiling value of $17,357.67 and an ultimate completion date of July 31, 2024. This award is placed against a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at up to $999,999,999, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $18,194.72, is for the supply of the drug Mounjaro (tirzepatide) 5 mg/0.5 mL pens. The contract has a firm fixed price pricing type and an ultimate completion date of May 21, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Mounjaro (tirzepatide) 7.5 mg/0.5 mL pens. The contract has a firm fixed price, ceiling value of $6,677.68, and runs through January 29, 2025. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug Mounjaro (Tirzepatide) 10 mg/0.5 ml pen. The contract has a ceiling value of $15,911.28 and runs through November 20, 2024. The contract was not set aside for any specific business type. AmerisourceBergen is the prime contractor, and the contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of the pharmaceutical product Mounjaro (tirzepatide) 5 mg/0.5 ml pen. The contract has a ceiling value of $9,091.60 and a period of performance through August 14, 2024. This order is placed against an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which has a potential value of up to $999,999,999 for the delivery of a wide...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication MOUNJARO (Tirzepatide) 5 mg/0.5 ml pens. The contract has a ceiling value of $4,734 and runs from September 13, 2024 to September 16, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. As a large pharmaceutical supplier, AmerisourceBergen holds several Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,321.04, is for the procurement of the medication Mounjaro (tirzepatide) 10 mg/0.5 ml pens. The contract has a firm fixed-price pricing type and an ultimate completion date of January 9, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB25FL7RL
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the procurement of the drug Mounjaro (Tirzepatide) 7.5 mg/0.5 mL pens. The order has a ceiling value of $11,055.50 and a completion date of February 4, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally.

Generated 5/21/25, 10:11 AM